Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03823703 · TERMINATED
Trial details
- NCT number
- NCT03823703
- Sponsor
- Corcept Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2021-04-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.